1,5-Diaryl substituted pyrazoles as p38 kinase inhibitors
US6509361B1 · kind B1 · utility
24Cited by
2References
57Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 12, 2001 |
| Grant date | Jan 21, 2003 |
| Priority date | — |
| Expiry date | Feb 12, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention contemplates 1,5-diaryl-substituted pyrazole compounds that, inter alia, inhibit the activity of p38 MAP kinase. Also contemplated by the invention are processes for the preparation of the contemplated compounds and for the use of a contemplated compound in treating a mammalian host having a p38 kinase- or TNF-mediated disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.